Tag Archives: british scientists

Antidepressants link to strokes for women

Middle-aged women who take antidepressants could be nearly 40 per cent more likely to have a stroke, scientists claim.

But it is unclear whether it is the pills or other factors linked to depression that raises the risk.

A study of more than 80,000 women aged 54 to 79 over a six-year period found those who had been depressed were 29 per cent more likely to have a stroke.

However, patients who took Prozac, Seroxat or similar medication were 39 per cent more at risk. Until recently there was little research on the long-term dangers of common antidepressants taken by millions of Britons a year.

But only last week a study by British scientists indicated they increased the risk of death, heart attacks and falls in the elderly.

Last year, 23million prescriptions were written out for Prozac, Seroxat and similar types of drugs known as SSRIs, a rise of more than 40 per cent in four years.

Last night, health experts said women should not stop taking their medication as they could not be sure it was causing strokes.

Prozac

Prozac

Patients with depression are often overweight, tend to smoke or fail to exercise, factors that also increase the risk of stroke, the U.S. researchers, from Harvard Medical School, in Boston, told the American Heart Association.

Kathryn Rexrode, senior author of the research said: ‘I don’t think the medications themselves are the primary cause of the risk. This study does not suggest that people should stop their medications to reduce the risk of stroke.

‘Depression can prevent individuals from controlling other medical problems such as diabetes and hypertension, from taking medications regularly or pursuing other healthy lifestyle measures such as exercise.


‘All these factors could contribute to increased risk.’

Dr Peter Coleman, of the Stroke Association, said patients on antidepressants should continue taking them.

‘Depression is a very serious condition which needs to be treated carefully by healthcare professionals. This research appears to indicate that women suffering from depression may be less motivated to maintain good health or control other medical conditions such as diabetes and high blood pressure, which have an associated increased risk of stroke.

‘However, it is very hard to determine whether there is a direct link between depression and stroke risk and a lot more research is needed in this area before depression alone can be viewed as a stroke risk factor.

‘It’s important that anyone taking antidepressants should continue doing so, and anyone concerned about their overall stroke risk should speak to their GP.’

Stem cell trial for multiple sclerosis

A global trial led by British scientists is to find out whether stem cells can safely be used to treat multiple sclerosis.

It will investigate if the cells can slow, stop and even reverse damage to the brain and spinal cord caused by MS.

The results will advance medical knowledge ‘by years’, scientists said.

The £10million trial, involving up to 200 patients around the world, is due to start later this year and will last between three and five years.

Scientists in the UK have received £1 million in joint funding from the MS Society and the UK Stem Cell Foundation for the UK arm of the trial as well as two other studies.

Paolo Muraro, lead researcher on the study based at Imperial College, London, said: ‘This is the first time that researchers from around the world have come together to test stem cell therapies in MS in such a large-scale clinical trial.

‘A trial of this scale would be impossible to run in one location, which is why this type of collaboration is essential if we are to make progress in this field.’

Multiple sclerosis

Multiple sclerosis

Researchers at trial sites in London and Edinburgh will harvest stem cells from the bone marrow of 13 participants, grow them in the laboratory and then re-inject them into the bloodstream.

The cells will make their way to the brain where it is hoped they will repair the damage caused by MS, which affects the central nervous system and causes problems with mobility, pain, extreme fatigue and muscle stiffness.

Scientists believe the new study will reduce the time taken to test whether stem cells could be a safe and effective treatment for people with MS by years, the MS Society said.

Simon Gillespie of the MS Society, which is contributing funding for the trial, said: ‘Stem cells hold tremendous potential as a future treatment option for people with MS.

‘We are delighted to be funding this world-leading piece of research which shows the power of an international research collaboration and joint working between charities.’


In recent years many people living with MS have been attracted to overseas stem cell clinics which claim to cure long-term conditions at a high price.

However there is no proven stem cell therapy available for MS anywhere in the world.

It is hoped that the research announced yesterday will eventually lead to a proven treatment and a reduction in the draw of foreign clinics.

Sir Richard Sykes, chairman of the UK Stem Cell Foundation, said: ‘I am delighted that by working in collaboration with the MS Society we have been able to progress these most promising research projects more quickly than by working in isolation.’

Of the two other studies funded by the MS Society and the UK Stem Cell Foundation, one based at Queen Mary Hospital, London, will look at how stem cells can be used to repair nerve damage in people with MS who have optic neuritis, a symptom of MS that can lead to temporary blindness.

The other, based at the University of Nottingham, will compare stem cells from people with a progressive form of MS to those without the condition with the aim of finding effective treatments.